Innventure, Inc.
Business
Innventure, Inc. founds, funds, and operates companies to commercialize transformative, sustainable technology solutions sourced or licensed from multinational corporations and other technology innovators. It develops and commercializes technology-driven products and services including polymer recycling and advanced conversion to petrochemical feedstocks (Refinity), curbside-recyclable flexible liquid packaging and filling systems (AeroFlexx), and direct-to-chip two-phase liquid cooling systems for data centers (Accelsius), alongside IP and manufacturing capabilities. Its key business segments are the Operating Companies, investment and management services, and the proprietary DownSelect commercialization process. Innventure scales and distributes solutions through strategic MNC channel partners, OEMs, CPG brands, data center operators, petrochemical customers, and centralized converting and filling networks across global markets.
Summary from filing dated 2025-04-14
Financials
Consolidated Statement of Income
| Concept | Trend | FY 2025 2025-12-31 | FY 2024 2024-12-31 | FY 2023 2023-12-31 |
|---|---|---|---|---|
| Revenue | 2 | — | 1 | |
| Cost of sales | 19 | — | 0 | |
| General and administrative | 67 | — | 18 | |
| Sales and marketing | 10 | — | 3 | |
| Research and development | 25 | — | 4 | |
| Goodwill impairment | 347 | 0 | — | |
| Total Operating Expenses | 467 | — | 25 | |
| Loss from Operations | −465 | — | −24 | |
| Interest expense, net | −10 | — | −1 | |
| Change in fair value of financial liabilities | 16 | — | 766,000 | |
| Equity method investment (loss) income | −13 | — | −632,000 | |
| Realized gain on conversion of available for sale investment | 2 | — | — | |
| Loss on conversion of promissory notes | 0 | — | — | |
| Write-off of loan commitment fee asset | 0 | — | 0 | |
| Miscellaneous other expense | −46,000 | — | 0 | |
| Total Non-operating (Expense) Income | −24 | — | −7 | |
| Loss before Income Taxes | −489 | — | −31 | |
| Income tax expense (benefit) | −13 | — | 0 | |
| Net Loss | −475 | — | −31 | |
| Non-redeemable non-controlling interest | −182 | — | −139,000 | |
| Net Loss Attributable to Innventure, Inc. Stockholders / Innventure LLC Unitholders | −293 | — | −31 | |
| Basic loss per unit (in usd per share) | −5.39 | — | — | |
| Diluted loss per share (in usd per share) | −5.39 | — | — | |
| Basic weighted average common shares (in shares) | 54 | — | — | |
| Diluted weighted average common shares (in shares) | 54 | — | — | |
| Unrealized gain (loss) on available-for-sale debt securities - related party | −662,000 | — | — | |
| Reclassification of realized gain (loss) on conversion of available for sale investments | −2 | — | — | |
| Total other comprehensive gain (loss), net of taxes | −2 | — | 0 | |
| Total comprehensive income (loss), net of taxes | −478 | — | −31 | |
| Non-redeemable non-controlling interest | −182 | — | — | |
| Net Comprehensive Loss Attributable to Innventure, Inc. Stockholders / Innventure LLC Unitholders | −295 | — | −31 |
Consolidated Balance Sheet
| Concept | Trend | FY 2025 2025-12-31 | FY 2024 2024-12-31 | FY 2024 2024-09-30 | FY 2023 2023-12-31 | FY 2022 2022-12-31 |
|---|---|---|---|---|---|---|
| Cash, cash equivalents and restricted cash | 60 | 11 | — | — | — | |
| Restricted cash | 5 | 0 | — | — | — | |
| Accounts receivable | 1 | 283,000 | — | 0 | — | |
| Due from related party | 12 | 5 | — | 3 | — | |
| Inventories | 2 | 5 | — | 0 | — | |
| Prepaid expenses and other current assets | 3 | 3 | — | 487,000 | — | |
| Total Current Assets | 83 | 24 | — | 6 | — | |
| Investments | 29 | 29 | — | 14 | — | |
| Property, plant and equipment, net | 2 | 1 | — | 637,000 | — | |
| Intangible assets, net | 161 | 182 | — | 0 | — | |
| Goodwill | 323 | 668 | — | 0 | — | |
| Other assets | 1 | 766,000 | — | 1 | — | |
| Total Assets | 599 | 905 | — | 22 | — | |
| Accounts payable | 3 | 3 | — | — | — | |
| Accrued employee benefits | 11 | 9 | — | 4 | — | |
| Accrued expenses | 7 | 2 | — | 1 | — | |
| Contract liabilities | 947,000 | 0 | — | — | — | |
| Patent installment payable - current | 700,000 | 1 | — | 775,000 | — | |
| Obligation to issue equity | 119,000 | 4 | — | 0 | — | |
| Warrant liability | 27 | 34 | — | 0 | — | |
| Income taxes payable | 23,000 | 0 | — | — | — | |
| Other current liabilities | 682,000 | 317,000 | — | 253,000 | — | |
| Total Current Liabilities | 76 | 69 | — | 8 | — | |
| Notes payable, net of current portion | 8 | 14 | — | — | — | |
| Earnout liability | 4 | 15 | — | 0 | — | |
| Stock-based compensation liability | 239,000 | 1 | — | 0 | — | |
| Patent installment payable, net of current | 12 | 12 | — | 13 | — | |
| Deferred income taxes | 14 | 27 | — | 0 | — | |
| Other liabilities | 556,000 | 355,000 | — | 683,000 | — | |
| Total Liabilities | 116 | 139 | — | 29 | — | |
| Commitments and Contingencies (Note 19) | — | — | — | — | — | |
| Common stock | 7,000 | 4,000 | — | — | — | |
| Additional paid-in capital | 577 | 503 | — | 0 | — | |
| Accumulated other comprehensive gain (loss) | −1 | 909,000 | — | 0 | — | |
| Accumulated deficit | −372 | −78 | — | −64 | — | |
| Total Innventure, Inc., Stockholders Equity | 204 | 426 | — | −20 | — | |
| Non-controlling interest | 279 | 341 | — | 2 | — | |
| Total Stockholders' Equity | 484 | 766 | −5 | −18 | −11 | |
| Total Liabilities and Stockholders Equity | 599 | 905 | — | 22 | — |
Consolidated Statement of Cash Flows
| Concept | Trend | FY 2025 2025-12-31 | FY 2023 2023-12-31 |
|---|---|---|---|
| Stock-based compensation | 28 | 910,000 | |
| Interest income on debt securities - related party | −394,000 | 0 | |
| Non-cash interest expense on notes payable | 7 | 487,000 | |
| Accrued unpaid interest on note payable | 336,000 | 0 | |
| Deferred income taxes | −13 | 0 | |
| Depreciation and amortization | 23 | 8,000 | |
| Other costs, net | 195,000 | — | |
| Accounts receivable | −811,000 | 0 | |
| Prepaid expenses and other current assets | −12 | −218,000 | |
| Inventory | 4 | 0 | |
| Accounts payable | −1 | 9,000 | |
| Accrued employee benefits | 2 | 3 | |
| Accrued expenses | −480,000 | 1 | |
| Stock-based compensation liability | −921,000 | 0 | |
| Income taxes payable | 23,000 | — | |
| Other current liabilities | −358,000 | −155,000 | |
| Contract liabilities | 947,000 | — | |
| Obligation to issue equity | 0 | 0 | |
| Other assets | −61,000 | −218,000 | |
| Patent installment payable | −525,000 | 0 | |
| Net Cash Used in Operating Activities | −81 | −19 | |
| Advances to equity method investee | 0 | 0 | |
| Acquisition of property, plant and equipment | −1 | −645,000 | |
| Acquisition of intangible assets | 0 | 0 | |
| Acquisition of net assets, net of cash acquired, through business combination | 0 | 0 | |
| Proceeds from sale of investments | 0 | 708,000 | |
| Cash withdrawn from trust as a result of business combination | 0 | 0 | |
| Net Cash (Used in) Provided by Investing Activities | −4 | −5 | |
| Proceeds from issuance of equity, net of issuance costs | 13 | 16 | |
| Proceeds from the issuance of equity to non-controlling interest, net of issuance costs | 71 | 337,000 | |
| Distributions to Stockholders | −76,000 | — | |
| Cash Flows Provided by Financing Activities | 139 | 19 | |
| Net Increase in Cash, Cash Equivalents and Restricted Cash | 54 | −5 | |
| Cash paid for interest | 0 | 297,000 | |
| Accretion of redeemable units to redemption value | 0 | 5 | |
| Debt discount and embedded derivative upon issuance | 0 | 1 | |
| Issuance of units to non-controlling interest in exchange of convertible promissory notes | 0 | 0 | |
| Conversion of working capital loans to equity method investees into investments in debt securities - related party | 4 | 0 | |
| Transfer of liability warrants to equity warrants in the Business Combination | 0 | 0 | |
| Initial recognition of loan commitment fee | 0 | 0 | |
| Transfer of loan commitment fee asset | 0 | 0 | |
| Recognition of right of use asset and corresponding lease liability | 927,000 | — | |
| Extinguishment of debt with Series C Preferred Stock | 14 | — | |
| Contribution of Series C Preferred Stock to equity method investee | 6 | — | |
| Conversion of AFX available-for-sale term loan into equity method investments | 9 | — | |
| Issuance of common stock as repayment of convertible debt | 47 | — | |
| Issuance of stock in exchange for services | 4 | — | |
| Conversion of preferred stock into common stock | 37 | — | |
| Transfer of Series C Preferred Stock from Mezzanine to Stockholders' equity | 1 | — | |
| Embedded derivative in association with Convertible Debentures | 2 | — | |
| Equity reallocation between non-controlling interest and additional paid-in capital | 37 | — | |
| Embedded derivative liability derecognition | 3 | — |